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IMPORTANCE Many studies have assessed racial/ethnic and sex disparities in the prevalence
of elevated blood pressure (BP) from childhood to adulthood, yet few have examined
differences in age-specific transitions between categories of BP over the life course in
contemporary, multiracial/multiethnic populations.
OBJECTIVE To estimate age, racial/ethnic, and sex–specific annual net transition probabilities
between categories of BP using Markov modeling of cross-sectional data from the National
Health and Nutrition Examination Survey.
DESIGN, SETTING, AND PARTICIPANTS National probability sample (National Health and
Nutrition Examination Survey in 2007-2008, 2009-2010, and 2011-2012) of 17 747 African
American, white American, and Mexican American participants aged 8 to 80 years. The data
were analyzed from September 2014 to November 2015.
MAIN OUTCOMES AND MEASURES Age-specific American Heart Association–defined BP
categories.
RESULTS Three National Health and Nutrition Examination Survey cross-sectional samples
were used to characterize the ages at which self-reported African American (n = 4973), white
American (n = 8886), and Mexican American (n = 3888) populations transitioned between
ideal BP, prehypertension, and hypertension across the life course. At age 8 years, disparities
in the prevalence of ideal BP were observed, with the prevalence being lower among boys
(86.6%-88.8%) compared with girls (93.0%-96.3%). From ages 8 to 30 years, annual net
transition probabilities from ideal to prehypertension among male individuals were more
than 2 times the net transition probabilities of their female counterparts. The largest net
transition probabilities for ages 8 to 30 years occurred in African American young men,
among whom a net 2.9% (95% CI, 2.3%-3.4%) of those with ideal BP transitioned to
prehypertension 1 year later. Mexican American young women aged 8 to 30 years
experienced the lowest ideal to prehypertension net transition probabilities (0.6%; 95% CI,
0.3%-0.8%). After age 40 years, ideal to prehypertension net transition probabilities
stabilized or decreased (range, 3.0%-4.5%) for men, whereas net transition probabilities for
women increased rapidly (range, 2.6%-13.0%). Mexican American women exhibited the
largest ideal to prehypertension net transition probabilities after age 60 years. The largest
prehypertension to hypertension net transition probabilities occurred at young ages in boys
of white race/ethnicity and African Americans, approximately age 8 years and age 25 years,
respectively, while net transition probabilities for white women and Mexican Americans
increased over the life course.
CONCLUSIONS AND RELEVANCE Heterogeneity in net transition probabilities from ideal BP
emerge during childhood, with associated rapid declines in ideal BP observed in boys and
African Americans, thus introducing disparities. Primordial prevention beginning in childhood
and into early adulthood is necessary to preempt the development of prehypertension and
hypertension, as well as associated racial/ethnic and sex disparities.
JAMA Cardiol. 2017;2(6):653-661. doi:10.1001/jamacardio.2017.0652
Published online April 19, 2017.
Author Affiliations: Department of
Epidemiology, The University of
North Carolina at Chapel Hill (Hardy,
Holliday, Engeda, Heiss, Avery);
Department of Biostatistics, The
University of North Carolina at Chapel
Hill (Chakladar, Lin, Zeng);
Department of Preventive Medicine,
Northwestern University, Chicago,
Illinois (Allen, Lloyd-Jones); Division
of Epidemiology & Community
Health, School of Public Health,
University of Minnesota, Minneapolis
(Schreiner); Department of Nutrition,
The University of North Carolina at
Chapel Hill (Shay).
Corresponding Author: Shakia T.
Hardy, MPH, Department of
Epidemiology, The University of
North Carolina at Chapel Hill, 137 E
Franklin St, Ste 306, Chapel Hill, NC
27514 (sthardy@live.unc.edu).
Heterogeneity in Blood Pressure Transitions
Over the Life Course
Age-Specific Emergence of Racial/Ethnic and Sex Disparities
in the United States
Shakia T. Hardy, MPH; Katelyn M. Holliday, PhD; Sujatro Chakladar, MS; Joseph C. Engeda, MPH; Norrina B. Allen, PhD; Gerardo Heiss, PhD, MD; 
Donald M. Lloyd-Jones, PhD; Pamela J. Schreiner, PhD; Christina M. Shay, PhD; Danyu Lin, PhD; Donglin Zeng, PhD; Christy L. Avery, PhD
H igh blood pressure (BP), the most common primarycare diagnosis in the United States, affects more than31% of adults1 and is a major risk factor for the devel-
opment of cardiovascular and renal diseases.2-4 Even el-
evated levels of BP below clinical treatment thresholds are
associated with increased subclinical atherosclerosis, target-
organ damage, and cardiovascular morbidity and mortality
compared with ideal BP.5,6 Increases in BP have been docu-
mented in childhood, with racial/ethnic minorities and young
men disproportionately contributing to the total US burden of
high BP at younger ages.1,7-11 Considering that half of the US
population develops high BP by age 60 years, characterizing
the ages at which populations transition between BP catego-
ries is needed to inform prevention and management efforts.12
Although the benefits of maintaining ideal levels of BP13-15
are well known, much of the literature characterizing changes
in BP across the life course relies on prevalence estimates ow-
ing to the lack of contemporary multiracial/multiethnic lon-
gitudinal studies spanning childhood to adulthood. While
cross-sectional data enable the estimation of the prevalence
of BP levels at consecutive ages, prevalence estimates do not
separate the counterbalancing probabilities of net transitions
between BP categories. A method that estimates net transi-
tion probabilities between BP categories from widely avail-
able cross-sectional data can overcome this deficiency and in-
form health policy for age-appropriate intervention strategies.
Herein, we used Markov-type net transition models specifi-
cally designed to estimate 1-year net transition probabilities
from cross-sectional data16 for the estimation of age, racial/
ethnic, and sex–specific net transition probabilities between
levels of BP over the life course.
[DBP]<80 mm Hg, untreated), prehypertension (SBP 120-139
mm Hg or DBP 80-89 mm Hg, treated or untreated), or hyper-
tension (SBP≥140 mm Hg or DBP≥90 mm Hg, treated or un-
treated) (eAppendix in the Supplement). For participants aged
8 to 19 years, BP was classified as ideal (<90th percentile by
age and sex), prehypertension (90th-95th percentiles or
SBP≥120 mm Hg or DBP≥80 mm Hg), or hypertension (>95th
percentile) using the American Heart Association guidelines.20
Given these category definitions, populations treated with an-
tihypertensive agents were ineligible for classification as ideal,
regardless of their BP level. Antihypertensive medication use
was determined by participant self-report.17
Statistical Analysis
We leveraged Markov-type transition models and cross-sectional
data to estimate 1-year net transition probabilities between BP
categories. As an example of net transition probabilities, consider
a hypothetical cohort of 70 participants aged 35 years, 50 with
ideal BP and 20 with prehypertension. If by age 36 years, 8 par-
ticipants with ideal BP transitioned to prehypertension and 3 par-
ticipants with prehypertension transitioned to ideal BP, the ideal
to prehypertension net transition would be 5 participants (ie, 8
minus 3); dividing by the number of participants with ideal BP
at age 35 years (n = 50) would yield a 1-year net transition prob-
ability of 10%. The 1-year net transition from prehypertension
to ideal BP is 0 because fewer participants transitioned from pre-
hypertension to ideal BP than from ideal to prehypertension (a
3-levelexampleisprovidedintheeAppendixintheSupplement).
Estimation of the individual transition probabilities instead of
net transition probabilities would require longitudinal data span-
ning adolescence to late adulthood, which are generally unavail-
able for multiracial/multiethnic populations, are not widely gen-
eralizable, or are outdated.
Using Markov-type models to estimate net transition prob-
abilities required 3 steps. First, we smoothed the data using
multinomial P-spline models to estimate the age, racial/
ethnic, and sex–specific smoothed prevalence of ideal BP, pre-
hypertension, and hypertension.21-23 Although BP was catego-
rized using percentiles for participants aged 8 to 19 years and
standard BP thresholds for participants 20 years or older, no
evidence of discontinuities by race/ethnicity or sex across the
2 age groups was observed; therefore, we present smoothed
Key Points
Question Does age at transition from ideal blood pressure and
prehypertension vary by race/ethnicity and sex?
Findings A cross-sectional study using Markov modeling indicates
that higher net transition probabilities away from ideal blood
pressure and prehypertension are observed among African
Americans and young men in early life, widening the racial/ethnic
and sex disparities observed in the burden of ideal and
prehypertension at age 8 years.
Meaning A focus on primordial prevention in childhood and early
adulthood is needed to preempt the development of




Three National Health and Nutrition Examination Survey 
(NHANES)17 cross-sectional samples (2007-2008, 2009-2010, 
and 2011-2012) were used to characterize the ages (range, 8-80 
years) at which self-reported African American (AA) (n = 4973), 
white American (WA) (n = 8886), and Mexican American (MA)
(n = 3888) populations transitioned between ideal BP, prehyper-
tension, and hypertension across the life course. This analysis 
began in September 2014 and was completed in November 2015. 
Participants who had a physical limitation on both arms (eg, 
rashes, casts, or edema) that prevented measurement of BP were 
excluded. We also excluded non-Hispanic Asian, other Hispanic, 
and other race/ethnicity (including multiracial/multiethnic) be-
cause of small sample sizes. Demographic and health informa-
tion collected in the study17 followed appropriate procedures for 
written informed consent, and the study was approved by local 
institutional review boards.
Three consecutive seated BP measurements were ob-
tained after a 5-minute rest by a trained examiner following a 
standardized protocol; the mean of the second and third read-
ings was used for analysis.18 For participants 20 years or older, 
BP was categorized using American Heart Association19 cut 
points as ideal (systolic BP [SBP]<120 mm Hg and diastolic BP
printed)
results across ages 8 to 80 years. Second, we used the smoothed
prevalence estimates to calculate the age, racial/ethnic, and
sex–specific net transition probabilities using a series of sim-
plex algorithms from linear programming theory (eAppendix
in the Supplement).16,24 Third, 95% CIs were calculated using
bootstrapping. Although all net transition probabilities pre-
sented herein are age, racial/ethnic, and sex–specific 1-year net
transition probabilities, the term net transition probability was
adopted to improve readability.
Calibration of Net Transition Probabilities
To represent the cost of moving from one BP category to an-
other, estimation of net transition probabilities required speci-
fication of a cost constant.16 Conceptually, the cost constant
reflected our belief that movement from ideal BP to hyperten-
sion (a 2-step movement) in 1 year was unlikely; instead, stay-
ing in the same BP category or a 1-step movement (ie, from ideal
BP to prehypertension or from prehypertension to ideal BP)
was more plausible. Results of our calibration investigation
using longitudinal Coronary Artery Risk Development in Young
Adults (CARDIA) Study25 data suggested that the cost con-
stants of 4, 8, and 17 were optimal for describing 0-step, 1-step,
and 2-step movements between BP categories (eAppendix in
the Supplement).
To place net transition probabilities in a population con-
text, estimates were extrapolated to the US population to evalu-
ate the net number of noninstitutionalized AAs, WAs, and MAs
transitioning between BP levels at each age. The net number
of individuals was calculated by multiplying the appropriate
net transition probabilities (relative scale) by the prevalence
of the BP category and the age, racial/ethnic, and sex–specific
2010 noninstitutionalized population size. Statistical analy-
ses were performed using the following software programs:
SAS version 9.3 (SAS Institute Inc), Stata 12 (StataCorp LP), and
R (The R Foundation).
Results
We analyzed 17 747 NHANES participants (28.0% AA, 50.1% WA,
and 21.9% MA) for whom BP measurements were available
(Table). The median age ranged from 33 to 44 years, with AAs and
MAs more likely to be younger and female compared with WAs.
Antihypertensive medication use varied by race/ethnicity, with
22.8% to 31.1% of AAs reporting antihypertensive medication use
compared with 9.8% to 12.7% among MAs. The median SBP and
DBP were also higher among AAs and WAs than among MAs.
At age 8 years, the prevalence of hypertension ranged from
1.0% to 1.6%, showing little difference by race/ethnicity or sex
(Figure 1). In contrast, disparities in the prevalence of ideal BP
and prehypertension were observed at this age, with a lower
prevalence of ideal BP among boys (86.6%-88.8%) compared
with girls (93.0%-96.3%) and, conversely, a higher preva-
lence of prehypertension among boys (10.0%-11.8%) com-
pared with girls (2.7%-5.9%). By age 19 years, disparities in the
prevalence of ideal BP (range, 67.9%-92.6%) and prehyper-
tension (range, 5.9%-26.6%) had widened, with AAs and boys
having the highest prevalence of prehypertension.
Estimated net transition probabilities across the life course
consistently demonstrated a transition from ideal BP to prehy-
pertension, with net transition probabilities being generally more
comparable by sex than race/ethnicity, particularly in early life
(Figure 2). From ages 8 to 30 years, annual net transition prob-
abilities from ideal BP to prehypertension became higher at each
consecutive age, with net transition probabilities among male
individuals being more than 2 times the net transition probabili-
ties of their female counterparts. At age 8 years, a net 1.4% (95%
CI, 1.2%-1.6%) of AA boys with ideal BP transitioned to prehyper-
tension by age 9 years compared with a net 0.6% (95% CI, 0.5%-
0.7%) of AA girls. The largest net transition probabilities over this
agerange(8-30years)wereobservedinAAyoungmen,forwhom
Table. Racial/Ethnic and Sex–Specific Demographics Used to Characterize Age-Specific Net Probability of Transitioning Between Ideal Blood Pressure,
Prehypertension, and Hypertensiona
Variable
African Americans White Americans Mexican Americans
Male Female Male Female Male Female
Unweighted No. 2445 2528 4498 4388 1963 1925
Age, median (IQR), y 37 (20-51) 39 (22-53) 43 (26-58) 44 (27-60) 33 (19-43) 33 (18-45)
Blood pressure category among adults
aged 20-80 y, %
Ideal 42.0 49.0 42.2 53.3 55.7 71.3
Prehypertension 40.0 34.3 44.0 34.3 34.4 20.4
Hypertension 18.0 16.7 13.7 12.4 9.8 8.2
Antihypertensive medication use, % 22.8 31.3 22.1 24.6 9.8 12.7
Blood pressure among adults aged 20-80 y,
median (IQR), mm Hg
Systolic 123 (114-135) 119 (109-133) 121 (113-130) 117 (107-129) 119 (112-128) 112 (105-123)
Diastolic 73 (65-81) 71 (62-78) 73 (65-79) 69 (63-76) 71 (64-78) 67 (80-74)
BMI, median (IQR) 27 (24-32) 31 (26-36) 28 (24-31) 27 (23-32) 28 (25-32) 29 (25-34)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided
by height in meters squared); IQR, interquartile range.
a In 17 747 National Health and Nutrition Examination Survey17 (2007-2012)
participants adjusted for sampling weights (except for N) to represent
noninstitutionalized, civilian, African American, White American, and Mexican
American US residents.
a net of 2.9% (95% CI, 2.3%-3.4%) of those with ideal BP transi-
tioned to prehypertension 1 year later. The lowest ideal to pre-
hypertension net transition probabilities (0.6%, 95% CI, 0.3%-
0.8%) were seen in MA young women aged 8 to 30 years.
Differences in net transition probabilities from ideal BP to pre-
hypertensionamongmenbyrace/ethnicitywereparticularlylarge
betweenages35and40years,withthelargestnettransitionprob-
abilities in this age range estimated among AA men aged 38 years
(4.5%; 95% CI, 4.0%-5.0%) and the smallest estimated among
MAmenaged35years(3.3%;95%CI,3.0%-3.6%).Atage40years,
ideal BP to prehypertension net transition probabilities for men
and women were approximately equal within racial/ethnic
groups. After age 40 years, net transition probabilities for men
decreased or remained constant, while net transition probabili-
ties for women increased rapidly (range, 2.6%-13.0%), with MA
women exhibiting the largest net transition probabilities from
ideal BP after age 60 years.
Similar to net transition probabilities from ideal BP to pre-
hypertension, net transition probabilities between prehyperten-
sion and hypertension consistently exhibited a net flow toward
higher BP categories compared with lower categories and hetero-
geneity by race/ethnicity and sex (Figure 3). In WA boys, esti-
mated net transition probabilities from prehypertension to hy-
pertension were highest at age 8 years, the earliest age under in-
vestigation (net transition probability, 1.2%; 95% CI, 0.7%-1.8%)
and slightly decreased over the life course until age 60 years. Pre-
hypertension to hypertension net transition probabilities for AA
boys at 8 years (net transition probability, 1.8%; 95% CI, 1.0%-
2.6%) were higher than those for WA boys and continued to be-
come higher until approximately a decade later at age 20 years
(net transition probability, 2.0%; 95% CI, 1.6%-2.4%); elevated
prehypertension to hypertension net transition probabilities for
AA women also accelerated into early adulthood at age 28 years
(net transition probability, 2.3%; 95% CI, 1.9%-2.7%). In contrast
to the net transition probabilities for AAs that decreased after
early adulthood, prehypertension to hypertension net transition
probabilities for WA women and MAs generally increased
throughout adulthood, with increases accelerating at approxi-
mately age 55 years.
When net transition probabilities were extrapolated to the
2010 US population of noninstitutionalized AAs, WAs, and MAs
aged 8 to 80 years, substantial differences between esti-
mated net transition probabilities and net increases in the
population were observed (Figure 4). These differences re-
flect both the relative magnitude of estimated net transition
probabilities and the size of the population eligible to transi-







































































































Shown are estimates in 17 747 National Health and Nutrition Examination Survey17 (2007-2012) participants.
tion into the adjacent BP category. For example, ideal BP to pre-
hypertension net transition probabilities among men peaked
at approximately age 40 years. Yet, when extrapolated to the
2010 US noninstitutionalized population, the largest age-
specific increases in the net number of men transitioning from
ideal BP to prehypertension occurred approximately 2 de-
cades earlier at age 20 years, with estimated 1-year net in-
creases of 6187 in AA men, 22 340 in WA men, and 4830 in MA
men. Although net transition probabilities from ideal BP to pre-
hypertension showed increases in net transition probabili-
ties into late life for AA, WA, and MA women, few partici-
pants with ideal BP remained; therefore, net increases in the
population with prehypertension peaked around age 45 years
for all racial/ethnic groups.
Discussion
Higher net transition probabilities away from ideal BP and pre-
hypertension observed among AAs and male individuals in early
life widened the racial/ethnic and sex disparities observed in the
burden of ideal BP and prehypertension at age 8 years. After
midlife, higher 1-year net transition probabilities from ideal BP
and prehypertension for women and MAs contributed to a higher
burden of hypertension in late life. However, when net transi-
tion probabilities were extrapolated to the US population, ear-
lier peaks were observed during young adulthood and midlife.
Together, these findings emphasize the importance of primor-
dial prevention early in life, particularly for AAs and men.6
Large-scale efforts to reduce the burden of elevated BP
and its sequelae have principally focused on the clinical man-
agement of BP in adults at levels that exceed actionable
thresholds.26 However, the high net transition probabilities to
prehypertension and hypertension at young ages reported
herein suggest that the biggest gains in primordial preven-
tion will occur from preventing transitions away from ideal BP
in children and young adults more resolutely, thereby neces-
sitating greater clinical and public health efforts to prevent or
delay the loss of ideal BP, sustained BP elevation, and dispari-
ties in the subpopulations most affected. A growing evidence
base supports efforts to decrease BP in early life (eg, through
increased physical activity and improved dietary intake), re-
gardless of changes in adiposity or starting BP level.27 In ad-
dition to school, family, and community–based programs,27,28
the high use of pediatric care services29 also offers an under-
used opportunity for physicians to promote healthy behav-
iors known to assist with the maintenance of ideal BP in child-
hood and connect families with community resources.30







































































































































Shown are estimates in 17 747 National Health and Nutrition Examination Survey17 (2007-2012) participants. Dashed lines indicate 95% CIs.
them at early risk for sustained loss of ideal BP.34-37 Consistent
with the literature on protective hormonal effects before
menopause,31 large net transition probabilities to prehyperten-
sion and hypertension were generally observed in older wom-
en compared with younger women.38,39 On the other hand, ex-
trapolations to the US population showed large net increases in
the population with prehypertension and hypertension in
midlife, further emphasizing the importance of primordial pre-
vention in early life before loss of ideal BP.
Reflecting perhaps a focus on clinically defined hyperten-
sion, much of the literature to date has concentrated on the pre-
vention of hypertension, with less emphasis placed on the tim-
ing of onset and duration of prehypertension and its influence
on the risk of downstream chronic disease.5,6,40 Although the
prevalence of hypertension has been stable for almost 2
decades,12 increases in prehypertension in early life extend the
period at risk for BP-associated cardiovascular and renal
complications.41,42 Therefore,theevaluationofage,racial/ethnic,
and sex–specific net transition probabilities between BP catego-
ries can identify epochs of increased vulnerability to develop-
ing prehypertension annually and suggest target groups, particu-
larly in early life, for health policy priorities and the allocation
resources. Studies that compare contemporary net transition
probabilities (estimated in earlier NHANES population cross-sec-







































































































































Shown are estimates in 17 747 National Health and Nutrition Examination Survey17 (2002-2012) participants. Dashed lines indicate 95% CIs.
Heterogeneity in racial/ethnic and sex–specific net transi-
tion probabilities to prehypertension and hypertension levels 
also documents important differences in the natural history of 
BP elevation31,32 and again invites a reassessment of an arche-
type that considers unfavorable BP levels an actionable attribute 
at middle age or late life. Of particular importance is the burden 
of undetected elevations of BP in early adulthood, especially 
among AA young men. For illustration, while the largest net tran-
sition probabilities to prehypertension and hypertension among 
AAs and men occurred between the second and fourth decades 
of life, 23% of the population aged 18 to 44 years reported no 
health care visit within the past year.33 Limited health care use 
during ages critical to BP transitions poses challenges that dis-
proportionately affect population subgroups and suggest the 
need for increased public health programs aimed at the preven-
tion of BP elevation in young adulthood. Public awareness of 
these large net transition probabilities could motivate individu-
als toward engagement with primary care during a period of life 
when such care is often a low priority. Research to test innova-
tive prevention and detection programs that reach populations 
known to be vulnerable to early elevations in BP in culturally and 
sex–appropriate settings are few but much needed, particularly 
for AAs and young men, whose increased salt sensitivity, early-
life covariate patterns, or hormonal predisposition may place
Reprinted)
tions) with net transition probabilities estimated in earlier waves
of the NHANES (eg, NHANES 1999-2000) can also help identify
changes in the ages at which large net transition probabilities to
prehypertension have occurred between these periods to gauge
vulnerabilities and trends.
Strengths and Limitations
Strengths of this study include the use of a novel approach to es-
timate annual net transition probabilities between BP categories
over the life course using contemporary cross-sectional data.
These results differentiate movement into a BP category from
movement out of it and uncover differences by subpopulations
that are potentially unseen using prevalence estimates. For ex-
ample, while the prevalence of prehypertension at ages 37 and
38 years was approximately 48.7% and 49.5%, respectively, for
AA and WA men, examination of the net transition probabilities
revealed that a net 4.5% (95% CI, 0.4%-0.5%) of AA men with
ideal BP at age 37 years transitioned to prehypertension by age
38 years compared with a net 3.3% (95% CI, 3.0%-3.6%) of
WA men. Unlike trajectories that often require longitudinal
follow-up,3,16,43-45 our use of net transition probabilities allows
for the use of data with current trends in BP in multiracial/
multiethnic populations to explore disparities over the life course
andincreasegeneralizabilityofresults,makingthisapproachwell
suited for future application when contemporary longitudinal
data are unattainable or when risk factor profiles in the popula-
tion rapidly change. Further strengths are contributed by the use
of NHANES data, a large, nationally representative multiracial/
multiethnic population inclusive of ages from childhood to late
adulthood and generalizable to approximately 86% of the US
racial/ethnic populations, with no exclusions for secondary
causes of hypertension.46
Several limitations of our data source and methods
should be noted. First, BP measurements were not collected
in NHANES on children younger than age 8 years, by which time
sizable proportions of the population had already transi-
tioned from ideal BP to prehypertension. As a result, net tran-
sition probabilities in children younger than age 8 years are not
described. Second, the timing of BP measurements and the tim-
ing of antihypertensive medication use were not available, as
is the case for other plausible correlates of BP that could have
introduced some degree of error in our estimates. Third, we
were unable to evaluate the influence of other factors that may
affect net transition probabilities (eg, obesity47 or marital
status48) because this examination would require further
stratification of our data, likely beyond the ability of the
current sample sizes. Fourth, individuals with elevated BP
that has been controlled to below the treatment threshold of





























































































































Shown are noninstitutionalized African American, white American, and Mexican American male individuals and female individuals.
Conclusions
Heterogeneity in net transition probabilities from ideal BP
emerge during childhood and early adolescence, with rapid de-
clines in ideal BP observed in boys or young men and AAs, thus
introducing disparities in desirable BP levels. This contempo-
rary and multiracial/multiethnic study of net transition prob-
abilities in AA, WA, and MA populations identified critical ages
for which primordial prevention efforts could target those with
increased susceptibility to transitioning to prehypertension and
hypertension across the life course. Our results suggest the
need for innovative clinical and public health partnerships that
develop and implement primordial prevention efforts in child-
hood and early adulthood to preempt racial/ethnic and sex dis-
parities in undesirable levels of BP.49
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